VG-1 (cell line)

{{For|the type of steel|VG-1 (steel)}}

{{Use dmy dates|date=March 2025}}

VG-1 is a B cell line which was derived from primary effusion lymphoma (PEL) {{Harv|Lu|Yang|Guasparri|Harrington|2009}}. It was first established in 2000 by David T. Scadden's group at Massachusetts General Hospital. It is infected with Kaposi's sarcoma-associated herpesvirus (KSHV), but negative with Epstein–Barr virus (EBV) {{Harv|Brander|Suscovich|Lee|Nguyen|2000}}.

References

  • {{Citation

| last1 = Brander

| first1 = C.

| last2 = Suscovich

| first2 = T.

| last3 = Lee

| first3 = Y.

| last4 = Nguyen

| first4 = P.T.

| last5 = O'Connor

| first5 = P.

| last6 = Seebach

| first6 = J.

| last7 = Jones

| first7 = N.G.

| last8 = van Gorder

| first8 = M.

| last9 = Walker

| first9 = B.D.

| last10 = Scadden

| first10 = D.T.

| year = 2000

| title = Impaired CTL Recognition of Cells Latently Infected with Kaposi's Sarcoma-Associated Herpes Virus

| periodical = J Immunol

| volume = 165

| issue = 4

| pages = 2077–83

| pmid = 10925292

| doi =10.4049/jimmunol.165.4.2077

| doi-access = free

}}

  • {{Citation

| last1 = Lu

| first1 = P.

| last2 = Yang

| first2 = C.

| last3 = Guasparri

| first3 = I.

| last4 = Harrington

| first4 = W.

| last5 = Wang

| first5 = Y.L.

| last6 = Cesarman

| first6 = E.

| year = 2009

| title = Early Events of B-cell Receptor Signaling are not Essential for the Proliferation and Viability of AIDS-Related Lymphoma

| periodical = Leukemia

| volume = 23

| issue = 4

| pages = 807–10

| pmid = 18987659

| doi =10.1038/leu.2008.304

| doi-access =

}}